Science Explorer Back to mapMap
Discussion
Researcher · Centre Léon Bérard · France

Raphaël F. Rousseau

Raphaël F. Rousseau publishes mostly in Immunology, Oncology and Neurology, on topics such as Neuroblastoma Research and Treatments, CAR-T cell therapy research and Virus-based gene therapy research.

ORCID 0000-0001-7288-5213 OpenAlex
World rank
#874,878
of 7,710,434 ranked researchers
Rank in France
#41,955
of 324,115
Works
170
Citations
3.3k
Citations per work
19.7
h-index
32
i10-index 43Top 13% in Immunology
Raphaël F. Rousseau

What does Raphaël F. Rousseau research?

Raphaël F. Rousseau's work is mostly in Medicine (29%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (12%).

Everything else: 76 works · 44.5% of their workHealth Sciences: 49 works · 29.1% of their workMedicine: 49 works · 29.1% of their workOncology: 20 works · 11.8% of their workNeurology: 17 works · 9.8% of their workSurgery: 13 works · 7.5% of their workLife Sciences: 45 works · 26.4% of their workBiochemistry, Genetics and Molecular Biology: 24 works · 14.3% of their workMolecular Biology: 13 works · 7.8% of their workGenetics: 11 works · 6.5% of their workImmunology and Microbiology: 21 works · 12.1% of their workImmunology: 21 works · 12.1% of their workTHEIR WORKRaphaël F.Rousseau170works
Life Sciences26%Health Sciences29%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else7644.5%
    1. Medicine4929.1%
    1. Biochemistry, Genetics and Molecular Biology2414.3%
    2. Immunology and Microbiology2112.1%
  1. 1Immunology12% of their works
  2. 2Oncology12% of their works
  3. 3Neurology10% of their works
  4. 4Molecular Biology8% of their works
  5. 5Surgery8% of their works
  6. 6Genetics6% of their works

Research topics

Which keywords describe Raphaël F. Rousseau's research?

The keywords of their largest research topics: Immunotherapy, Cancer Immunotherapy, Tumor Regression, ALK, Neuroblastoma, Gene Therapy, CAR T Cells and Chimeric Antigen Receptor.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Immunotherapy674 topics
  2. Cancer Immunotherapy402 topics
  3. Tumor Regression312 topics
  4. ALK261 topic
  5. Neuroblastoma261 topic
  6. Gene Therapy252 topics
  7. CAR T Cells231 topic
  8. Chimeric Antigen Receptor231 topic
  9. AAV171 topic
  10. Dendritic Cells171 topic
  11. Immunity171 topic
  12. Viral Vectors171 topic
  13. Glioblastoma101 topic
  14. NK Cell Recognition101 topic
  15. Natural Killer Cells101 topic
  16. Temozolomide101 topic
  17. Bacterial Therapy81 topic
  18. Fc Receptors81 topic
  19. Therapeutic Antibodies81 topic
  20. Tumor Targeting81 topic

Where does Raphaël F. Rousseau work?

Raphaël F. Rousseau's main affiliation in the publication record is Centre Léon Bérard, France.

How many publications and citations does Raphaël F. Rousseau have?

OpenAlex counts 170 works and 3,342 citations for Raphaël F. Rousseau, an h-index of 32, ranking #874,878 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Raphaël F. Rousseau. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.